Lilly, Mannkind, Cumberland in spotlight
August 17, 2010 at 10:31 AM EDT
Eli Lilly & Co. shares fall on news it is ceasing development of a late-stage drug candidate for the treatment of Alzheimer's disease.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.